Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RRM1 known ✓ | P23921 | 1/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.41 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.39 |
| ▸ | NPY4R | P50391 | 7/20 | 0.39 |
| ▸ | NPY1R | P25929 | 5/20 | 0.39 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.37 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.37 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.37 |
| ▸ | NPY2R | P49146 | 4/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.36 |
| ▸ | OTC | P00480 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL22411245 | 1.00 | DPP7 (0.41) | DPP7NOD1NPY4RNPY1RGNAI3 | |
| Hydrochloric Acid SCHEMBL2897702 | 1.00 | DPP7 (0.41) | DPP7NOD1NPY4RNPY1RGNAI3 | |
| Hydrochloric Acid SCHEMBL1487716 | 1.00 | DPP7 (0.41) | DPP7NOD1NPY4RNPY1RGNAI3 | |
| Hydrochloric Acid SCHEMBL570000 | 1.00 | DPP7 (0.41) | DPP7NOD1NPY4RNPY1RGNAI3 | |
| SCHEMBL93607 | 0.98 | DPP7 (0.42) | DPP7NOD1NPY4RNPY1RGNAI3 | |
| SCHEMBL9330200 | 0.98 | DPP7 (0.42) | DPP7NOD1NPY4RNPY1RGNAI3 | |
| SCHEMBL93606 | 0.98 | DPP7 (0.42) | DPP7NOD1NPY4RNPY1RGNAI3 | |
| Water SCHEMBL28810239 | 0.97 | DPP7 (0.41) | DPP7NOD1NPY4RNPY1RGNAI3 | |
| SCHEMBL31592761 | 0.97 | DPP7 (0.41) | DPP7NOD1NPY4RNPY1RGNAI3 | |
| Acetic Acid SCHEMBL12077668 | 0.94 | NOD1 (0.40) | DPP7NOD1NPY4RNPY1RGNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117362202-A | Preparation method and equipment of lauroyl arginine ethyl ester hydrochloride | 南通市杰阳生物科技有限公司 | 2024-01-09 | — | — | CN | claimed |
| CN-108101812-B | Production and purification process of lauroyl arginine ethyl ester hydrochloride | 成都傲飞生物化学品有限责任公司 | 2020-12-25 | — | — | CN | claimed |
| CN-107400069-B | Preparation method of lauroyl arginine ethyl ester hydrochloride | 浙江大学 | 2020-02-21 | — | — | CN | claimed |
| CN-108101812-A | A kind of production purifying process of lauroyl arginine ethyl ester hydrochloride | 成都傲飞生物化学品有限责任公司 | 2018-06-01 | — | — | CN | claimed |
| CN-107400069-A | A kind of preparation method of lauroyl arginine ethyl ester hydrochloride | 浙江大学 | 2017-11-28 | — | — | CN | claimed |
| EP-3010537-A2 | Methods for the prevention of aggregation of viral components | De Staat der Nederlanden, vert. door de minister Van VWS, Ministerie van Volksgezondheid, Welzijn en Sport (NL) | 2016-04-27 | — | — | EP | claimed |
| WO-2014204303-A2 | Methods for the prevention of aggregation of viral components | DE STAAT DER NEDERLANDEN, VERT. DOOR DE MINISTER VAN VWS, MINISTERIE VAN VOLKSGEZONDHEID, WELZIJN EN SPORT (NL) | 2014-12-24 | — | — | WO | claimed |
| WO-2003056002-A1 | IMPROVEMENT IN AMYLASE STABILITY | UNISEARCH LIMITED (AU) | 2003-07-10 | — | — | WO | claimed |
| WO-2003056001-A1 | MODIFIED ENZYMES AND MODIFICATION PROCESSES | UNISEARCH (AU) | 2003-07-10 | — | — | WO | claimed |
| WO-2003056000-A1 | MODIFIED ENZYME AND MODIFICATION PROCESS | UNISEARCH (AU) | 2003-07-10 | — | — | WO | claimed |
| US-5780658-A | Process for the synthesis of cationic surfactants comprising esterification with basic character amino acids | LABORATORIOS MIRET, S.A. (ES) | 1998-07-14 | — | — | US | claimed |
| CN-1091952-A | Cosmetic composition | UNILEVER NV (NL) | 1994-09-14 | — | — | CN | claimed |
| US-12472448-B2 | Compact hydroxamate-based affinity tags for artificially tagging biological macromolecules | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-11-18 | — | — | US | disclosed |
| US-12030850-B2 | Method for producing ester based on eco-friendly and high-efficiency esterification by using base exchange of salt and the compound thereof | WOODWARD BIO CORP. (KR) | 2024-07-09 | — | — | US | disclosed |
| CN-117362202-A | Preparation method and equipment of lauroyl arginine ethyl ester hydrochloride | 南通市杰阳生物科技有限公司 | 2024-01-09 | — | — | CN | disclosed |
| CN-117362202-A | Preparation method and equipment of lauroyl arginine ethyl ester hydrochloride | 南通市杰阳生物科技有限公司 | 2024-01-09 | — | — | CN | disclosed |
| WO-1996038460-A1 | PALLADIUM CATALYZED NUCLEOSIDE MODIFICATION METHODS USING NUCLEOPHILES AND CARBON MONOXIDE | NEXSTAR PHARMACEUTICALS, INC. (US) | 1996-12-05 | — | — | WO | disclosed |
| EP-0666729-A1 | COSMETIC COMPOSITION | UNILEVER PLC (GB) | 1995-08-16 | — | — | EP | disclosed |
| CN-1091952-A | Cosmetic composition | UNILEVER NV (NL) | 1994-09-14 | — | — | CN | disclosed |
| WO-1994009750-A1 | COSMETIC COMPOSITION | UNILEVER PLC (GB) | 1994-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12030850-B2 | Method for producing ester based on eco-friendly and high-efficiency esterification by using base exchange of salt and the compound thereof | SLC6A9, TST, SLC6A5 | RRM1 1072/4885DPP7 1954/4885NOD1 2669/4885 |
| US-12472448-B2 | Compact hydroxamate-based affinity tags for artificially tagging biological macromolecules | HLCS, AADAC, HYPK | RRM1 3618/4885DPP7 2140/4885NOD1 2584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.